CVE-2019-2616
Published: March 25, 2022
Official Description
Oracle BI Publisher, formerly XML Publisher, contains an unspecified vulnerability that allows for various unauthorized actions. Open-source reporting attributes this vulnerability to allowing for authentication bypass.
CISA KEV Advisory
Oracle BI Publisher Unauthorized Access Vulnerability
Oracle BI Publisher, formerly XML Publisher, contains an unspecified vulnerability that allows for various unauthorized actions. Open-source reporting attributes this vulnerability to allowing for authentication bypass.
Apply updates per vendor instructions.
Risk Analysis
Oracle BI Publisher contains an unspecified vulnerability that allows for unauthorized actions, including authentication bypass. The high EPSS score of 0.94226 indicates a significant likelihood of exploitation. This vulnerability is confirmed to be actively exploited, as listed in the CISA KEV catalog.
This vulnerability is actively exploited in the wild. Open-source reporting attributes this to an authentication bypass flaw.
Apply the latest security patches and updates for Oracle BI Publisher. Review and strengthen authentication mechanisms and access controls.
Technical Analysis
CVE-2019-2616 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2019-2616 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Affected Vendors & Products
Exploit & PoC Resources
All References (1)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2019-2616 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1